Dr Reddy’s Laboratories (DRL) has informed that it will strengthen the commercial roll-out of of the Russian vaccine Sputnik V in the coming weeks.
The nation-wide soft launch of Sputnik V has thus far reached over 50 cities and towns across India.
The Hyderabad-based pharma major has tied up with RDIF of Russia for marketing Sputnik V in India. The Sputnik V vaccine was launched on a soft pilot basis in India on May 14.
PLUSS to provide transport, storage solution to Dr Reddy’s for Sputnik V vaccine
The company, in a Twitter update on the status of Sputnik vaccine, said: “Neither the ongoing soft commercial launch nor work towards its ramp up in India have been put on hold.”
Starting initially in Hyderabad, the roll out of Sputnik V has scaled up speedily and reached over 50 cities and towns.
Fortis, Apollo roll out Sputnik V at 2 hospitals in Delhi-NCR
Dr Reddy’s has partnered with major hospitals across the country for this purpose, all of whom have administered Sputnik V in India, including ongoing commercial roll- out to the public, it informed in a Twitter statement.
Comments
Comments have to be in English, and in full sentences. They cannot be abusive or personal. Please abide by our community guidelines for posting your comments.
We have migrated to a new commenting platform. If you are already a registered user of TheHindu Businessline and logged in, you may continue to engage with our articles. If you do not have an account please register and login to post comments. Users can access their older comments by logging into their accounts on Vuukle.